Literature DB >> 26763340

Practice Patterns and Opinions on Current Clinical Practice Guidelines Regarding the Management of Delirium in the Intensive Care Unit.

Yoonsun Mo1, Anthony E Zimmermann1, Michael C Thomas1.   

Abstract

OBJECTIVE: The aim of this study was to determine current delirium practices in the intensive care unit (ICU) setting and evaluate awareness and adoption of the 2013 Pain, Agitation, and Delirium (PAD) guidelines with emphasis on delirium management. DESIGN, SETTING, AND PARTICIPANTS: A large-scale, multidisciplinary, online survey was administered to physician, pharmacist, nurse, and mid-level practitioner members of the Society of Critical Care Medicine (SCCM) between September 2014 and October 2014. A total of 635 respondents completed the survey.
MEASUREMENTS AND MAIN RESULTS: Nonpharmacologic interventions such as early mobilization were used in most ICUs (83%) for prevention of delirium. A majority of respondents (97%) reported using pharmacologic agents to treat hyperactive delirium. Ninety percent of the respondents answered that they were aware of the 2013 PAD guidelines, and 75% of respondents felt that their delirium practices have been changed as a result of the new guidelines. In addition, logistic regression analysis of this study showed that respondents who use delirium screening tools were twice more likely to be fully aware of key components of the updated guidelines (odds ratio [OR] = 2.07, 95% confidence interval [CI] = 1.20-3.60).
CONCLUSIONS: Most critical care practitioners are fully aware and knowledgeable of key recommendations in the new guidelines and have changed their delirium practices accordingly.

Entities:  

Keywords:  critical care; delirium; intensive care unit; prevention; survey; treatment

Mesh:

Year:  2016        PMID: 26763340     DOI: 10.1177/0897190015625396

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  2 in total

1.  Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial.

Authors:  Mark van den Boogaard; Arjen J C Slooter; Roger J M Brüggemann; Lisette Schoonhoven; Albertus Beishuizen; J Wytze Vermeijden; Danie Pretorius; Jan de Koning; Koen S Simons; Paul J W Dennesen; Peter H J Van der Voort; Saskia Houterman; J G van der Hoeven; Peter Pickkers; Anna Besselink; Lieuwe S Hofstra; Peter E Spronk; Walter van den Bergh; Dirk W Donker; Malaika Fuchs; Attila Karakus; M Koeman; Mirella van Duijnhoven; Gerjon Hannink
Journal:  JAMA       Date:  2018-02-20       Impact factor: 56.272

2.  Effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial.

Authors:  Clémence Louis; Thomas Godet; Gérald Chanques; Nathalie Bourguignon; Dominique Morand; Bruno Pereira; Jean-Michel Constantin
Journal:  Trials       Date:  2018-06-04       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.